title: Long-term management of scalp psoriasis: perspectives from the International Psoriasis Council.
abstract: The scalp is a well-known predilection site for psoriasis. Epidemiological data on the various manifestations of scalp psoriasis as well as on its therapeutic management are sparse. The understanding of the natural course of scalp psoriasis is relevant for its therapeutic management. In over 25% of patients, scalp psoriasis is the first signal of the psoriatic condition. Nevertheless, few of the therapies currently used for the treatment of scalp psoriasis have been evaluated for efficacy in the setting of well-designed, well-controlled clinical studies. The lack of comparative data impedes the interpretation of the results from studies of scalp psoriasis. Long-term studies of the efficacy and safety of scalp treatments are lacking. Moreover, clinical studies generally do not incorporate quality of life impact or mechanisms to enhance adherence thus hindering the optimal management of the patient over the long-term. Consequently, this report will evaluate the available data and the associated factors to be considered in the development of a treatment paradigm for the long-term management of the scalp psoriasis patient.
authors.affiliation: Department of Dermatology, Århus University Hospital, Århus, Denmark. knudkrag@rm.dk
authors.forename: Knud
authors.initials: K
authors.lastname: Kragballe
authors.forename: Alan
authors.initials: A
authors.lastname: Menter
authors.forename: Mark
authors.initials: M
authors.lastname: Lebwohl
authors.forename: Paul W
authors.initials: PW
authors.lastname: Tebbey
authors.forename: Peter C M
authors.initials: PC
authors.lastname: van de Kerkhof
mesh_terms: D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006203:Hair Preparations / Q000627:therapeutic use; D006801:Humans; D008134:Long-Term Care; D010349:Patient Compliance; D010358:Patient Participation; D011565:Psoriasis / Q000188:drug therapy / Q000628:therapy*; D011788:Quality of Life; D012536:Scalp Dermatoses / Q000188:drug therapy / Q000628:therapy*; D014807:Vitamin D / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; D006203:Hair Preparations; D014807:Vitamin D